BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 8061575)

  • 1. Vasectomy and prostate cancer risk in China.
    Hsing AW; Wang RT; Gu FL; Lee M; Wang T; Leng TJ; Spitz M; Blot WJ
    Cancer Epidemiol Biomarkers Prev; 1994 Jun; 3(4):285-8. PubMed ID: 8061575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate cancer and vasectomy: a hospital-based case-control study in China, Nepal and the Republic of Korea.
    Schwingl PJ; Meirik O; Kapp N; Farley TM;
    Contraception; 2009 May; 79(5):363-8. PubMed ID: 19341848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasectomy and prostate cancer.
    Lesko SM; Louik C; Vezina R; Rosenberg L; Shapiro S
    J Urol; 1999 Jun; 161(6):1848-52; discussion 1852-3. PubMed ID: 10332451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasectomy and risk of prostate cancer.
    Stanford JL; Wicklund KG; McKnight B; Daling JR; Brawer MK
    Cancer Epidemiol Biomarkers Prev; 1999 Oct; 8(10):881-6. PubMed ID: 10548316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphic CAG/CAA repeat length in the AIB1/SRC-3 gene and prostate cancer risk: a population-based case-control study.
    Hsing AW; Chokkalingam AP; Gao YT; Wu G; Wang X; Deng J; Cheng J; Sesterhenn IA; Mostofi FK; Chiang T; Chen YL; Stanczyk FZ; Chang C
    Cancer Epidemiol Biomarkers Prev; 2002 Apr; 11(4):337-41. PubMed ID: 11927493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The safety of vasectomy: recent concerns.
    Farley TM; Meirik O; Mehta S; Waites GM
    Bull World Health Organ; 1993; 71(3-4):413-9. PubMed ID: 8324861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphic CAG and GGN repeat lengths in the androgen receptor gene and prostate cancer risk: a population-based case-control study in China.
    Hsing AW; Gao YT; Wu G; Wang X; Deng J; Chen YL; Sesterhenn IA; Mostofi FK; Benichou J; Chang C
    Cancer Res; 2000 Sep; 60(18):5111-6. PubMed ID: 11016637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sexually transmitted diseases and other urogenital conditions as risk factors for prostate cancer: a case--control study in Wayne County, Michigan.
    Patel DA; Bock CH; Schwartz K; Wenzlaff AS; Demers RY; Severson RK
    Cancer Causes Control; 2005 Apr; 16(3):263-73. PubMed ID: 15947878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Body size and prostate cancer: a population-based case-control study in China.
    Hsing AW; Deng J; Sesterhenn IA; Mostofi FK; Stanczyk FZ; Benichou J; Xie T; Gao YT
    Cancer Epidemiol Biomarkers Prev; 2000 Dec; 9(12):1335-41. PubMed ID: 11142419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-like growth factors and prostate cancer: a population-based case-control study in China.
    Chokkalingam AP; Pollak M; Fillmore CM; Gao YT; Stanczyk FZ; Deng J; Sesterhenn IA; Mostofi FK; Fears TR; Madigan MP; Ziegler RG; Fraumeni JF; Hsing AW
    Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):421-7. PubMed ID: 11352850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate cancer is not increased in men with vasectomy in denmark.
    Lynge E
    J Urol; 2002 Aug; 168(2):488-90. PubMed ID: 12131294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis.
    Gann PH; Ma J; Giovannucci E; Willett W; Sacks FM; Hennekens CH; Stampfer MJ
    Cancer Res; 1999 Mar; 59(6):1225-30. PubMed ID: 10096552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sexual behaviour, history of sexually transmitted diseases, and the risk of prostate cancer: a case-control study in Cuba.
    Fernández L; Galán Y; Jiménez R; Gutiérrez A; Guerra M; Pereda C; Alonso C; Riboli E; Agudo A; González C
    Int J Epidemiol; 2005 Feb; 34(1):193-7. PubMed ID: 15375086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mass screening-based case-control study of diet and prostate cancer in Changchun, China.
    Li XM; Li J; Tsuji I; Nakaya N; Nishino Y; Zhao XJ
    Asian J Androl; 2008 Jul; 10(4):551-60. PubMed ID: 18478158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphic markers in the SRD5A2 gene and prostate cancer risk: a population-based case-control study.
    Hsing AW; Chen C; Chokkalingam AP; Gao YT; Dightman DA; Nguyen HT; Deng J; Cheng J; Sesterhenn IA; Mostofi FK; Stanczyk FZ; Reichardt JK
    Cancer Epidemiol Biomarkers Prev; 2001 Oct; 10(10):1077-82. PubMed ID: 11588134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasectomy and prostate cancer: a case-control study in India.
    Platz EA; Yeole BB; Cho E; Jussawalla DJ; Giovannucci E; Ascherio A
    Int J Epidemiol; 1997 Oct; 26(5):933-8. PubMed ID: 9363512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obesity and the risk of prostate cancer.
    Porter MP; Stanford JL
    Prostate; 2005 Mar; 62(4):316-21. PubMed ID: 15389806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Vasectomy not associated with prostate cancer: a meta-analysis].
    Tang LF; Jiang H; Shang XJ; Zhao LM; Bai Q; Hong K; Liu DF; Liu JM; Yuan RP; Chen Q; Ma LL
    Zhonghua Nan Ke Xue; 2009 Jun; 15(6):545-50. PubMed ID: 19593998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obesity, adipokines, and prostate cancer in a prospective population-based study.
    Baillargeon J; Platz EA; Rose DP; Pollock BH; Ankerst DP; Haffner S; Higgins B; Lokshin A; Troyer D; Hernandez J; Lynch S; Leach RJ; Thompson IM
    Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1331-5. PubMed ID: 16835332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial aspects of prostate cancer: a case control study.
    Keetch DW; Rice JP; Suarez BK; Catalona WJ
    J Urol; 1995 Dec; 154(6):2100-2. PubMed ID: 7500468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.